Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Scientific abstracts: Featured research at the 2019 Society of Family Planning Annual Meeting.

Teal S, Haider S, Harris L, Hubacher D, Raine-Bennett T.

Contraception. 2019 Jul 23:303-304. doi: 10.1016/j.contraception.2019.07.007. [Epub ahead of print] No abstract available.

PMID:
31472941
2.

Identification and validation of uterine perforation, intrauterine device expulsion, and breastfeeding in four health care systems with electronic health records.

Anthony MS, Armstrong MA, Getahun D, Scholes D, Gatz J, Schulze-Rath R, Postlethwaite D, Merchant M, Alabaster AL, Chillemi G, Raine-Bennett T, Xie F, Chiu VY, Im TM, Takhar HS, Fassett M, Grafton J, Cronkite D, Ichikawa L, Reed SD, Hui SL, Ritchey ME, Saltus CW, Andrews EB, Rothman KJ, Asiimwe A, Lynen R, Schoendorf J.

Clin Epidemiol. 2019 Jul 23;11:635-643. doi: 10.2147/CLEP.S201044. eCollection 2019.

3.

Depot Medroxyprogesterone Acetate, Oral Contraceptive, Intrauterine Device Use, and Fracture Risk.

Raine-Bennett T, Chandra M, Armstrong MA, Alexeeff S, Lo JC.

Obstet Gynecol. 2019 Sep;134(3):581-589. doi: 10.1097/AOG.0000000000003414.

PMID:
31403601
4.

Prediction of Occult Uterine Sarcoma before Hysterectomy for Women with Leiomyoma or Abnormal Bleeding.

Lentz SE, Zaritsky E, Tucker LY, Lee C, Lazo IM, Niihara A, Yamamoto M, Raine-Bennett T.

J Minim Invasive Gynecol. 2019 Jul 25. pii: S1553-4650(19)30321-8. doi: 10.1016/j.jmig.2019.07.017. [Epub ahead of print]

PMID:
31352067
5.

Viral coinfection analysis using a MinHash toolkit.

Dawson ET, Wagner S, Roberson D, Yeager M, Boland J, Garrison E, Chanock S, Schiffman M, Raine-Bennett T, Lorey T, Castle PE, Mirabello L, Durbin R.

BMC Bioinformatics. 2019 Jul 12;20(1):389. doi: 10.1186/s12859-019-2918-y.

6.

Human papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: Whole viral genome sequences from 7116 HPV16-positive women.

Clifford GM, Tenet V, Georges D, Alemany L, Pavón MA, Chen Z, Yeager M, Cullen M, Boland JF, Bass S, Steinberg M, Raine-Bennett T, Lorey T, Wentzensen N, Walker J, Zuna R, Schiffman M, Mirabello L.

Papillomavirus Res. 2019 Jun;7:67-74. doi: 10.1016/j.pvr.2019.02.001. Epub 2019 Feb 6.

7.

Risk of cardiovascular disease in women with BRCA1 and BRCA2 mutations.

Powell CB, Alabaster A, Armstrong MA, Stoller N, Raine-Bennett T.

Gynecol Oncol. 2018 Dec;151(3):489-493. doi: 10.1016/j.ygyno.2018.10.010. Epub 2018 Oct 10.

PMID:
30314670
8.

Contraception after Abortion and Risk of Repeated Unintended Pregnancy among Health Plan Members.

Postlethwaite D, Lee J, Merchant M, Alabaster A, Raine-Bennett T.

Perm J. 2018;22:18-058. doi: 10.7812/TPP/18-058.

9.

Scientific abstracts featured research at the 2018 North American Forum on Family Planning.

Teal S, Borrero S, Hubacher D, Madden T, Raine-Bennett T.

Contraception. 2018 Oct;98(4):329-330. doi: 10.1016/j.contraception.2018.07.007. Epub 2018 Jul 19. No abstract available.

PMID:
30031790
10.

The Relationship Between Prescription Copayments and Contraceptive Adherence in a New-user Cohort.

Marshall C, Schmittdiel J, Chandra M, Calhoun A, Raine-Bennett T.

Med Care. 2018 Jul;56(7):577-582. doi: 10.1097/MLR.0000000000000921.

11.

Recent intrauterine device use and the risk of precancerous cervical lesions and cervical cancer.

Averbach S, Silverberg MJ, Leyden W, Smith-McCune K, Raine-Bennett T, Sawaya GF.

Contraception. 2018 Apr 17. pii: S0010-7824(18)30144-6. doi: 10.1016/j.contraception.2018.04.008. [Epub ahead of print]

12.

Automated Cervical Screening and Triage, Based on HPV Testing and Computer-Interpreted Cytology.

Yu K, Hyun N, Fetterman B, Lorey T, Raine-Bennett TR, Zhang H, Stamps RE, Poitras NE, Wheeler W, Befano B, Gage JC, Castle PE, Wentzensen N, Schiffman M.

J Natl Cancer Inst. 2018 Nov 1;110(11):1222-1228. doi: 10.1093/jnci/djy044.

13.

Validation of a Human Papillomavirus (HPV) DNA Cervical Screening Test That Provides Expanded HPV Typing.

Demarco M, Carter-Pokras O, Hyun N, Castle PE, He X, Dallal CM, Chen J, Gage JC, Befano B, Fetterman B, Lorey T, Poitras N, Raine-Bennett TR, Wentzensen N, Schiffman M.

J Clin Microbiol. 2018 Apr 25;56(5). pii: e01910-17. doi: 10.1128/JCM.01910-17. Print 2018 May.

14.

Bone loss in women with BRCA1 and BRCA2 mutations.

Powell CB, Alabaster A, Stoller N, Armstrong MA, Salyer C, Hamilton I, Raine-Bennett T.

Gynecol Oncol. 2018 Mar;148(3):535-539. doi: 10.1016/j.ygyno.2018.01.013.

PMID:
29422346
15.

Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency across 12 Genotypes and Potential Impact on Management of HPV-Positive Women.

Clarke MA, Gradissimo A, Schiffman M, Lam J, Sollecito CC, Fetterman B, Lorey T, Poitras N, Raine-Bennett TR, Castle PE, Wentzensen N, Burk RD.

Clin Cancer Res. 2018 May 1;24(9):2194-2202. doi: 10.1158/1078-0432.CCR-17-3251. Epub 2018 Feb 2.

16.

Epidemiologic Evidence That Excess Body Weight Increases Risk of Cervical Cancer by Decreased Detection of Precancer.

Clarke MA, Fetterman B, Cheung LC, Wentzensen N, Gage JC, Katki HA, Befano B, Demarco M, Schussler J, Kinney WK, Raine-Bennett TR, Lorey TS, Poitras NE, Castle PE, Schiffman M.

J Clin Oncol. 2018 Apr 20;36(12):1184-1191. doi: 10.1200/JCO.2017.75.3442. Epub 2018 Jan 22.

17.

Exploring young women's decisional needs for contraceptive method choice: a qualitative study.

Marshall C, Kandahari N, Raine-Bennett T.

Contraception. 2018 Mar;97(3):243-248. doi: 10.1016/j.contraception.2017.10.004. Epub 2017 Oct 13.

PMID:
29038070
18.

HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis.

Mirabello L, Yeager M, Yu K, Clifford GM, Xiao Y, Zhu B, Cullen M, Boland JF, Wentzensen N, Nelson CW, Raine-Bennett T, Chen Z, Bass S, Song L, Yang Q, Steinberg M, Burdett L, Dean M, Roberson D, Mitchell J, Lorey T, Franceschi S, Castle PE, Walker J, Zuna R, Kreimer AR, Beachler DC, Hildesheim A, Gonzalez P, Porras C, Burk RD, Schiffman M.

Cell. 2017 Sep 7;170(6):1164-1174.e6. doi: 10.1016/j.cell.2017.08.001.

19.

Scientific abstracts featured research at the 2017 Scientific abstracts featured research at the 2017 North American Forum on Family PlanningNorth American Forum on Family Planning.

Espey E, Teal S, Borrero S, Raine-Bennett T, Finer L.

Contraception. 2017 Oct;96(4):263-264. doi: 10.1016/j.contraception.2017.07.162. Epub 2017 Aug 1. No abstract available.

PMID:
28774665
20.

Adjuvant gemcitabine-docetaxel chemotherapy for stage I uterine leiomyosarcoma: Trends and survival outcomes.

Littell RD, Tucker LY, Raine-Bennett T, Palen TE, Zaritsky E, Neugebauer R, Embry-Schubert J, Lentz SE.

Gynecol Oncol. 2017 Oct;147(1):11-17. doi: 10.1016/j.ygyno.2017.07.122. Epub 2017 Jul 24.

PMID:
28747255
21.

Assessment of a New Lower-Cost Real-Time PCR Assay for Detection of High-Risk Human Papillomavirus: Useful for Cervical Screening in Limited-Resource Settings?

Fokom Domgue J, Schiffman M, Wentzensen NH, Gage JC, Castle PE, Raine-Bennett TR, Fetterman B, Lorey T, Poitras NE, Befano B, Xie Y, Miachon LS, Dean M.

J Clin Microbiol. 2017 Aug;55(8):2348-2355. doi: 10.1128/JCM.00492-17. Epub 2017 May 17.

22.

Minimally Invasive Hysterectomy and Power Morcellation Trends in a West Coast Integrated Health System.

Zaritsky E, Tucker LY, Neugebauer R, Chou T, Flanagan T, Walter AJ, Raine-Bennett T.

Obstet Gynecol. 2017 Jun;129(6):996-1005. doi: 10.1097/AOG.0000000000002034.

PMID:
28486359
23.

Over-the-Counter Access to Oral Contraceptives for Adolescents.

Upadhya KK, Santelli JS, Raine-Bennett TR, Kottke MJ, Grossman D.

J Adolesc Health. 2017 Jun;60(6):634-640. doi: 10.1016/j.jadohealth.2016.12.024. Epub 2017 Mar 14. Review.

PMID:
28314704
24.

Patient perceptions of a decision support tool to assist with young women's contraceptive choice.

Marshall C, Nuru-Jeter A, Guendelman S, Mauldon J, Raine-Bennett T.

Patient Educ Couns. 2017 Feb;100(2):343-348. doi: 10.1016/j.pec.2016.08.022. Epub 2016 Aug 24.

PMID:
27578270
25.

A cohort study of cervical screening using partial HPV typing and cytology triage.

Schiffman M, Hyun N, Raine-Bennett TR, Katki H, Fetterman B, Gage JC, Cheung LC, Befano B, Poitras N, Lorey T, Castle PE, Wentzensen N.

Int J Cancer. 2016 Dec 1;139(11):2606-15. doi: 10.1002/ijc.30375. Epub 2016 Aug 26.

26.

Featured research at the 2016 North American Forum on Family Planning.

Espey E, Teal S, Borrero S, Raine-Bennett T, Finer L.

Contraception. 2016 Oct;94(4):385-6. doi: 10.1016/j.contraception.2016.07.189. Epub 2016 Jul 28. No abstract available.

PMID:
27477065
27.

Experience With Opportunistic Salpingectomy in a Large, Community-Based Health System in the United States.

Garcia C, Martin M, Tucker LY, Lyon L, Armstrong MA, McBride-Allen S, Littell RD, Alabaster A, Raine-Bennett T, Powell CB.

Obstet Gynecol. 2016 Aug;128(2):277-83. doi: 10.1097/AOG.0000000000001531.

PMID:
27399999
28.

HPV16 Sublineage Associations With Histology-Specific Cancer Risk Using HPV Whole-Genome Sequences in 3200 Women.

Mirabello L, Yeager M, Cullen M, Boland JF, Chen Z, Wentzensen N, Zhang X, Yu K, Yang Q, Mitchell J, Roberson D, Bass S, Xiao Y, Burdett L, Raine-Bennett T, Lorey T, Castle PE, Burk RD, Schiffman M.

J Natl Cancer Inst. 2016 Apr 29;108(9). pii: djw100. doi: 10.1093/jnci/djw100. Print 2016 Sep.

29.

Improved Perinatal Depression Screening, Treatment, and Outcomes With a Universal Obstetric Program.

Avalos LA, Raine-Bennett T, Chen H, Adams AS, Flanagan T.

Obstet Gynecol. 2016 May;127(5):917-25. doi: 10.1097/AOG.0000000000001403.

30.

Effects of relationship context on contraceptive use among young women.

Upadhyay UD, Raifman S, Raine-Bennett T.

Contraception. 2016 Jul;94(1):68-73. doi: 10.1016/j.contraception.2016.02.025. Epub 2016 Mar 16.

31.

Occult Uterine Sarcoma and Leiomyosarcoma: Incidence of and Survival Associated With Morcellation.

Raine-Bennett T, Tucker LY, Zaritsky E, Littell RD, Palen T, Neugebauer R, Axtell A, Schultze PM, Kronbach DW, Embry-Schubert J, Sundang A, Bischoff K, Compton-Phillips AL, Lentz SE.

Obstet Gynecol. 2016 Jan;127(1):29-39. doi: 10.1097/AOG.0000000000001187. Erratum in: Obstet Gynecol. 2016 Feb;127(2):405.

PMID:
26646120
32.

Deep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection.

Cullen M, Boland JF, Schiffman M, Zhang X, Wentzensen N, Yang Q, Chen Z, Yu K, Mitchell J, Roberson D, Bass S, Burdette L, Machado M, Ravichandran S, Luke B, Machiela MJ, Andersen M, Osentoski M, Laptewicz M, Wacholder S, Feldman A, Raine-Bennett T, Lorey T, Castle PE, Yeager M, Burk RD, Mirabello L.

Papillomavirus Res. 2015 Dec 1;1:3-11.

33.

A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results.

Schiffman M, Vaughan LM, Raine-Bennett TR, Castle PE, Katki HA, Gage JC, Fetterman B, Befano B, Wentzensen N.

Gynecol Oncol. 2015 Sep;138(3):573-8. doi: 10.1016/j.ygyno.2015.06.040. Epub 2015 Jul 4.

34.

Featured research at the 2015 North American Forum on Family Planning.

Espey E, Borrero S, Raine-Bennett T, Finer L, Teal S.

Contraception. 2015 Oct;92(4):357-8. doi: 10.1016/j.contraception.2015.06.024. Epub 2015 Jul 2. No abstract available.

35.

Development of a brief questionnaire to assess contraceptive intent.

Raine-Bennett TR, Rocca CH.

Patient Educ Couns. 2015 Nov;98(11):1425-30. doi: 10.1016/j.pec.2015.05.016. Epub 2015 Jun 3.

36.

The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test.

Schiffman M, Boyle S, Raine-Bennett T, Katki HA, Gage JC, Wentzensen N, Kornegay JR, Apple R, Aldrich C, Erlich HA, Tam T, Befano B, Burk RD, Castle PE.

Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1304-10. doi: 10.1158/1055-9965.EPI-14-1353. Epub 2015 Jun 18.

37.

Reproductive health outcomes of insured adolescent and adult women who access oral levonorgestrel emergency contraception.

Raine-Bennett T, Merchant M, Sinclair F, Lee JW, Goler N.

Obstet Gynecol. 2015 Apr;125(4):904-11. doi: 10.1097/AOG.0000000000000742.

38.

A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening results.

Schiffman M, Burk RD, Boyle S, Raine-Bennett T, Katki HA, Gage JC, Wentzensen N, Kornegay JR, Aldrich C, Tam T, Erlich H, Apple R, Befano B, Castle PE.

J Clin Microbiol. 2015 Jan;53(1):52-9. doi: 10.1128/JCM.02116-14. Epub 2014 Oct 22.

39.

HPV16 methyl-haplotypes determined by a novel next-generation sequencing method are associated with cervical precancer.

Mirabello L, Frimer M, Harari A, McAndrew T, Smith B, Chen Z, Wentzensen N, Wacholder S, Castle PE, Raine-Bennett T, Schiffman M, Burk RD.

Int J Cancer. 2015 Feb 15;136(4):E146-53. doi: 10.1002/ijc.29119. Epub 2014 Sep 3.

40.

Risk management options elected by women after testing positive for a BRCA mutation.

Garcia C, Wendt J, Lyon L, Jones J, Littell RD, Armstrong MA, Raine-Bennett T, Powell CB.

Gynecol Oncol. 2014 Feb;132(2):428-33. doi: 10.1016/j.ygyno.2013.12.014. Epub 2013 Dec 16.

PMID:
24355485
41.

The authors reply.

Rocca CH, Harper CC, Raine-Bennett TR.

Perspect Sex Reprod Health. 2013 Jun;45(2):113-4. No abstract available.

PMID:
23901444
42.

In reply.

Raine-Bennett T.

Obstet Gynecol. 2013 May;121(5):1111. doi: 10.1097/AOG.0b013e3182900166. No abstract available.

PMID:
23635760
43.

Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management.

Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK.

J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S78-84. doi: 10.1097/LGT.0b013e31828543c5.

44.

Follow-up testing after colposcopy: five-year risk of CIN 2+ after a colposcopic diagnosis of CIN 1 or less.

Katki HA, Gage JC, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Kinney WK.

J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S69-77. doi: 10.1097/LGT.0b013e31828543b1.

45.

Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years.

Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK.

J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S64-8. doi: 10.1097/LGT.0b013e3182854399.

46.

Five-year risks of CIN 3+ and cervical cancer among women who test Pap-negative but are HPV-positive.

Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK.

J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S56-63. doi: 10.1097/LGT.0b013e318285437b.

47.

Five-year risks of CIN 3+ and cervical cancer among women with HPV-positive and HPV-negative high-grade Pap results.

Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK.

J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S50-5. doi: 10.1097/LGT.0b013e3182854282.

48.

Five-year risks of CIN 2+ and CIN 3+ among women with HPV-positive and HPV-negative LSIL Pap results.

Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK.

J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S43-9. doi: 10.1097/LGT.0b013e3182854269.

49.

Five-year risks of CIN 3+ and cervical cancer among women with HPV testing of ASC-US Pap results.

Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK.

J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S36-42. doi: 10.1097/LGT.0b013e3182854253.

50.

Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines.

Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK.

J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S28-35. doi: 10.1097/LGT.0b013e318285423c.

Supplemental Content

Loading ...
Support Center